Literature DB >> 32886024

Licochalcone A, a licorice flavonoid: antioxidant, cytotoxic, genotoxic, and chemopreventive potential.

Karoline Soares de Freitas1, Iara Silva Squarisi1, Nathália Oliveira Acésio1, Heloiza Diniz Nicolella1, Saulo Duarte Ozelin1, Matheus Reis Santos de Melo1, Ana Paula Prado Guissone1, Gabriela Fernandes1, Lívia Mara Silva2, Ademar Alves da Silva Filho2, Denise Crispim Tavares1.   

Abstract

Licochalcone A (LicoA) is a flavonoid derived from Glycyrrhiza spp. plants. The present study aimed to investigate the antioxidant, cytotoxic, genotoxic, and chemopreventive effects of LicoA in in vitro and in vivo systems. The results showed that LicoA (197.1 μM) scavenged 77.92% of free radicals. Concentrations of 147.75 µM or higher LicoA produced cytotoxicity in Chinese hamster ovary (CHO) fibroblasts. LicoA treatments of 4.43 to 10.34 µM did not exert genotoxic activity, but at 11.8 µM significantly lowered nuclear division indexes, compared to negative control, revealing cytotoxicity. Lower concentrations (1.85 to 7.39 µM) exhibited protective activity against chromosomal damage induced by doxorubicin (DXR) or methyl methanesulfonate (MMS) in CHO cells. LicoA exerted no marked influence on DXR-induced genotoxicity in mouse erythrocytes, but reduced pre-neoplastic lesions induced by 1,2-dimethylhydrazine (DMH) in rat colon at 3.12 to 50 mg/kg b.w. Biochemical markers and body weight indicated no apparent toxicity. These findings contribute to better understanding the mechanisms underlying LicoA-initiated activity as a promising chemopreventive compound. ABBREVIATIONS: AC, aberrant crypts; ACF, aberrant crypt foci; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BOD, biochemical oxygen demand; CHO, Chinese hamster ovary fibroblast; DMH, 1,2-dimethylhydrazine; DMSO, dimethyl sulfoxide; DPPH, 2,2-diphenyl-1-picrylhydrazyl; DXR, doxorubicin hydrochloride; EDTA, ethylenediaminetetraacetic acid; GA, gallic acid; LicoA, licochalcone A; MMS, methyl methanesulfonate; MNBC, micronucleated binucleated cells; MNPCE, micronucleated polychromatic erythrocyte; NCE, normochromatic erythrocyte; NDI, nuclear division index; PBS, phosphate-buffered saline; PCE, polychromatic erythrocyte; XTT, 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide.

Entities:  

Keywords:  Glycyrrhiza spp; anticarcinogenicity; antigenotoxicity

Mesh:

Substances:

Year:  2020        PMID: 32886024     DOI: 10.1080/15287394.2020.1813228

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  5 in total

1.  Mechanisms of Penetration Enhancement and Transport Utilizing Skin Keratine Liposomes for the Topical Delivery of Licochalcone A.

Authors:  Wenfeng Wu; Zhuxian Wang; Yufan Wu; Huiyi Wu; Tingting Chen; Yaqi Xue; Yuan Wang; Cuiping Jiang; Chunyan Shen; Li Liu; Hongxia Zhu; Qiang Liu
Journal:  Molecules       Date:  2022-04-13       Impact factor: 4.927

2.  Licochalcone A Promotes the Ubiquitination of c-Met to Abrogate Gefitinib Resistance.

Authors:  Shuangze Han; Xiaoying Li; Yu Gan; Wei Li
Journal:  Biomed Res Int       Date:  2022-03-10       Impact factor: 3.411

3.  Development of Peptide Targeted PLGA-PEGylated Nanoparticles Loading Licochalcone-A for Ocular Inflammation.

Authors:  Ruth Galindo; Elena Sánchez-López; María José Gómara; Marta Espina; Miren Ettcheto; Amanda Cano; Isabel Haro; Antoni Camins; María Luisa García
Journal:  Pharmaceutics       Date:  2022-01-26       Impact factor: 6.321

4.  Protective Effect of Resveratrol against Hexavalent Chromium-Induced Genotoxic Damage in Hsd:ICR Male Mice.

Authors:  Tonancy Nicolás-Méndez; Sam Kacew; Alda Rocío Ortiz-Muñiz; Víctor Manuel Mendoza-Núñez; María Del Carmen García-Rodríguez
Journal:  Molecules       Date:  2022-06-23       Impact factor: 4.927

5.  Therapeutic effects of shaogan fuzi decoction in rheumatoid arthritis: Network pharmacology and experimental validation.

Authors:  Lu Shi; Yiying Zhao; Chenran Feng; Feng Miao; Linlin Dong; Tianquan Wang; Antony Stalin; Jingyuan Zhang; Jingru Tu; Kexin Liu; Wenyan Sun; Jiarui Wu
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.